{"title":"早期乳腺癌保乳手术后省略放疗的安全性分析:基于随机对照试验的meta分析","authors":"Xiaoming Zhang, Yu Chen, Qingping Wu, Yifei Yu, Jingqi Chen, Luchuang Qian","doi":"10.1002/jso.70091","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and objectives: </strong>The safety of omitting radiotherapy (RT) after breast-conserving surgery (BCS) in patients with early-stage breast cancer (BC) remains controversial. This study investigates the safety of omitting RT after BCS.</p><p><strong>Methods: </strong>In accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, we conducted a comprehensive search of PubMed, Web of Science, EMBASE, and the Cochrane Library to identify eligible randomized controlled trials (RCTs). The primary outcomes were local recurrence (LR) and overall survival (OS), while secondary outcomes included distant metastasis (DM), disease-free survival (DFS), and disease-specific survival (DSS). The analysis was conducted using hazard ratios (HRs) and 95% confidence intervals (CIs).</p><p><strong>Results: </strong>A total of 14 RCTs involving 11 977 early-stage BC patients who underwent BCS were included in this meta-analysis. Compared with patients who received RT, those who omitted RT had a significantly higher LR (HR = 2.76; p < 0.001), but no significant difference was observed in OS between the two groups (HR = 1.05; p = 0.208). The DFS was significantly better in the RT group than in the no-RT group (HR = 1.29; p = 0.001). No significant differences were observed between the two groups in DM (HR = 0.96; p = 0.729) or DSS (HR = 1.03; p = 0.754). Subgroup analyses revealed that omitting RT was associated with a higher LR across different follow-up periods, age stratifications, and types of BC invasiveness, but no significant impact on OS was found.</p><p><strong>Conclusions: </strong>This study found that in patients with early-stage BC, omitting RT after BCS increased the LR compared with the RT group, but did not affect the OS.</p><p><strong>Trial registration: </strong>PROSPERO (CRD420250655104).</p>","PeriodicalId":17111,"journal":{"name":"Journal of Surgical Oncology","volume":" ","pages":""},"PeriodicalIF":1.9000,"publicationDate":"2025-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Safety Analysis of Omitting Radiotherapy After Breast-Conserving Surgery in Patients With Early-Stage Breast Cancer: A Meta-Analysis Based on Randomized Controlled Trials.\",\"authors\":\"Xiaoming Zhang, Yu Chen, Qingping Wu, Yifei Yu, Jingqi Chen, Luchuang Qian\",\"doi\":\"10.1002/jso.70091\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background and objectives: </strong>The safety of omitting radiotherapy (RT) after breast-conserving surgery (BCS) in patients with early-stage breast cancer (BC) remains controversial. This study investigates the safety of omitting RT after BCS.</p><p><strong>Methods: </strong>In accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, we conducted a comprehensive search of PubMed, Web of Science, EMBASE, and the Cochrane Library to identify eligible randomized controlled trials (RCTs). The primary outcomes were local recurrence (LR) and overall survival (OS), while secondary outcomes included distant metastasis (DM), disease-free survival (DFS), and disease-specific survival (DSS). The analysis was conducted using hazard ratios (HRs) and 95% confidence intervals (CIs).</p><p><strong>Results: </strong>A total of 14 RCTs involving 11 977 early-stage BC patients who underwent BCS were included in this meta-analysis. Compared with patients who received RT, those who omitted RT had a significantly higher LR (HR = 2.76; p < 0.001), but no significant difference was observed in OS between the two groups (HR = 1.05; p = 0.208). The DFS was significantly better in the RT group than in the no-RT group (HR = 1.29; p = 0.001). No significant differences were observed between the two groups in DM (HR = 0.96; p = 0.729) or DSS (HR = 1.03; p = 0.754). Subgroup analyses revealed that omitting RT was associated with a higher LR across different follow-up periods, age stratifications, and types of BC invasiveness, but no significant impact on OS was found.</p><p><strong>Conclusions: </strong>This study found that in patients with early-stage BC, omitting RT after BCS increased the LR compared with the RT group, but did not affect the OS.</p><p><strong>Trial registration: </strong>PROSPERO (CRD420250655104).</p>\",\"PeriodicalId\":17111,\"journal\":{\"name\":\"Journal of Surgical Oncology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":1.9000,\"publicationDate\":\"2025-09-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Surgical Oncology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1002/jso.70091\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Surgical Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/jso.70091","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
背景与目的:早期乳腺癌(BC)患者保乳手术(BCS)后省略放疗(RT)的安全性仍存在争议。本研究探讨BCS术后省略RT的安全性。方法:根据系统评价和荟萃分析的首选报告项目(PRISMA)指南,我们对PubMed、Web of Science、EMBASE和Cochrane图书馆进行了全面的检索,以确定符合条件的随机对照试验(RCTs)。主要结局是局部复发(LR)和总生存(OS),次要结局包括远处转移(DM)、无病生存(DFS)和疾病特异性生存(DSS)。采用风险比(hr)和95%置信区间(ci)进行分析。结果:本荟萃分析共纳入14项随机对照试验,涉及11,977例接受BCS的早期BC患者。结论:本研究发现,早期BC患者,BCS后不进行RT的患者LR较RT组增加,但不影响OS。试验注册:PROSPERO (CRD420250655104)。
Safety Analysis of Omitting Radiotherapy After Breast-Conserving Surgery in Patients With Early-Stage Breast Cancer: A Meta-Analysis Based on Randomized Controlled Trials.
Background and objectives: The safety of omitting radiotherapy (RT) after breast-conserving surgery (BCS) in patients with early-stage breast cancer (BC) remains controversial. This study investigates the safety of omitting RT after BCS.
Methods: In accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, we conducted a comprehensive search of PubMed, Web of Science, EMBASE, and the Cochrane Library to identify eligible randomized controlled trials (RCTs). The primary outcomes were local recurrence (LR) and overall survival (OS), while secondary outcomes included distant metastasis (DM), disease-free survival (DFS), and disease-specific survival (DSS). The analysis was conducted using hazard ratios (HRs) and 95% confidence intervals (CIs).
Results: A total of 14 RCTs involving 11 977 early-stage BC patients who underwent BCS were included in this meta-analysis. Compared with patients who received RT, those who omitted RT had a significantly higher LR (HR = 2.76; p < 0.001), but no significant difference was observed in OS between the two groups (HR = 1.05; p = 0.208). The DFS was significantly better in the RT group than in the no-RT group (HR = 1.29; p = 0.001). No significant differences were observed between the two groups in DM (HR = 0.96; p = 0.729) or DSS (HR = 1.03; p = 0.754). Subgroup analyses revealed that omitting RT was associated with a higher LR across different follow-up periods, age stratifications, and types of BC invasiveness, but no significant impact on OS was found.
Conclusions: This study found that in patients with early-stage BC, omitting RT after BCS increased the LR compared with the RT group, but did not affect the OS.
期刊介绍:
The Journal of Surgical Oncology offers peer-reviewed, original papers in the field of surgical oncology and broadly related surgical sciences, including reports on experimental and laboratory studies. As an international journal, the editors encourage participation from leading surgeons around the world. The JSO is the representative journal for the World Federation of Surgical Oncology Societies. Publishing 16 issues in 2 volumes each year, the journal accepts Research Articles, in-depth Reviews of timely interest, Letters to the Editor, and invited Editorials. Guest Editors from the JSO Editorial Board oversee multiple special Seminars issues each year. These Seminars include multifaceted Reviews on a particular topic or current issue in surgical oncology, which are invited from experts in the field.